One man's DNA became a pillar of genetics
The Human Genome Project used DNA from donor RP11 extensively, raising ethical concerns about consent and privacy. Despite deviations from initial promises, the project's genome remains crucial for genetics research, highlighting ethical challenges in scientific endeavors.
Read original article
The Human Genome Project, a groundbreaking initiative to map the human genetic code, relied heavily on the DNA of an anonymous donor known as RP11. Initially, volunteers were promised anonymity and minimal use of their DNA in the published genome. However, when the draft was released in 2001, nearly 75% of it came from RP11. Recent investigations reveal ethical concerns, including DNA sourced from a cadaver and project scientists. Despite the project's high ethical standards, the overreliance on RP11 raises questions about informed consent and privacy. The project's leaders, under pressure to complete the sequencing, veered from their principles. The genome derived from the project, with RP11's DNA at its core, continues to be a vital resource in genetics research. The story sheds light on the complexities and ethical dilemmas faced during one of biology's most significant endeavors, impacting the research enterprise and potential benefits that could arise from it.
Related
Bridge RNAs direct programmable recombination of target and donor DNA
Researchers discovered a novel Bridge RNA mechanism enabling precise DNA recombination. The IS110 system allows programmable DNA rearrangements, offering insights into genetic diversity and genome design beyond CRISPR and RNA interference.
Bridge RNAs direct programmable recombination of target and donor DNA
Researchers discovered a novel Bridge RNA mechanism enabling precise DNA recombination. The IS110 system allows targeted DNA insertion, excision, and inversion, offering insights into genetic diversity and genome manipulation for genetic engineering.
New technique opens the door to large-scale DNA editing to cure diseases
Researchers have described a new genetic editing mechanism using jumping genes to insert DNA sequences accurately. This system shows promise in overcoming CRISPR limitations, with 94% accuracy and 60% efficiency in bacteria. Optimizations are needed for mammalian cell use.
DNA-based bacterial parasite uses new DNA-editing method
Researchers found a new DNA parasite, IS110, using unique DNA-editing to move in bacterial genomes. It inserts DNA with non-protein-coding RNAs as guides, showing potential for gene editing despite high error rates. Refinement needed for safety and accuracy in vertebrate genomes.
The strategy behind one of the most successful labs in the world
The Laboratory of Molecular Biology in Cambridge, UK, renowned for Nobel laureates and DNA research, attributes success to diverse talent, stable funding, and innovative management fostering scientific breakthroughs and technology integration.
0 commentsRelated
Bridge RNAs direct programmable recombination of target and donor DNA
Researchers discovered a novel Bridge RNA mechanism enabling precise DNA recombination. The IS110 system allows programmable DNA rearrangements, offering insights into genetic diversity and genome design beyond CRISPR and RNA interference.
Bridge RNAs direct programmable recombination of target and donor DNA
Researchers discovered a novel Bridge RNA mechanism enabling precise DNA recombination. The IS110 system allows targeted DNA insertion, excision, and inversion, offering insights into genetic diversity and genome manipulation for genetic engineering.
New technique opens the door to large-scale DNA editing to cure diseases
Researchers have described a new genetic editing mechanism using jumping genes to insert DNA sequences accurately. This system shows promise in overcoming CRISPR limitations, with 94% accuracy and 60% efficiency in bacteria. Optimizations are needed for mammalian cell use.
DNA-based bacterial parasite uses new DNA-editing method
Researchers found a new DNA parasite, IS110, using unique DNA-editing to move in bacterial genomes. It inserts DNA with non-protein-coding RNAs as guides, showing potential for gene editing despite high error rates. Refinement needed for safety and accuracy in vertebrate genomes.
The strategy behind one of the most successful labs in the world
The Laboratory of Molecular Biology in Cambridge, UK, renowned for Nobel laureates and DNA research, attributes success to diverse talent, stable funding, and innovative management fostering scientific breakthroughs and technology integration.